HRCM
Hawk Ridge Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-214,376
| Closed | -$76.8M | – | 42 |
|
|
2023
Q3 | $76.8M | Buy |
214,376
+100
| +0% | +$35.8K | 3.78% | 11 |
|
|
2023
Q2 | $81.2M | Buy |
214,276
+66,500
| +45% | +$25.2M | 4.31% | 8 |
|
|
2023
Q1 | $70.8M | Buy |
147,776
+42,990
| +41% | +$20.6M | 4.02% | 10 |
|
|
2022
Q4 | $44.1M | Buy |
104,786
+6,100
| +6% | +$2.56M | 2.98% | 15 |
|
|
2022
Q3 | $41.2M | Buy |
+98,686
| New | +$41.2M | 2.59% | 18 |
|